Shudong Wang

University of South Australia

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (10)

Richard Head

University of South Australia

AUSTRALIA

View details

Gary Heinemann

University of South Australia

AUSTRALIA

View details

Mingfeng Yu

University of South Australia

AUSTRALIA

View details

MANJUN LI

University of South Australia

AUSTRALIA

View details

Muhammed Hamidur Rahaman

University of South Australia

AUSTRALIA

View details

Stuart Cook

Centenary Institute

AUSTRALIA

View details

Jessamy Tiffen

University of Sydney

AUSTRALIA

View details

Theodosia Teo

University of South Australia

AUSTRALIA

View details

Matthew Sykes

University of South Australia

AUSTRALIA

View details

Hugo Albrecht

University of South Australia

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shudong Wang

Research Interests

Explore related searches

Contact this professor

Articles (10)

Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation

Kinase inhibitors: Opportunities for small molecule anticancer immunotherapies

Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition

Discovery of Potent Inhibitors of Cyclin‐Dependent Kinases 7 and 9: Design, Synthesis, Structure‐Activity Relationship Analysis and Biological Evaluation

Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer

Combined In Silico and In Vitro Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells

An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia

Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target

A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma

Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation

Collaborators (10)

Richard Head

Gary Heinemann

Mingfeng Yu

MANJUN LI

Muhammed Hamidur Rahaman

Stuart Cook

Jessamy Tiffen

Theodosia Teo

Matthew Sykes

Hugo Albrecht

Make your next move.